002826 易明醫藥
按盤價 
16.830 +0.320 (+1.938%)
16.830 +0.320 (+1.938%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.376 | 11.907 | 6.190 | 2.065 | 6.035 |
| 總資產報酬率 ROA (%) | 1.853 | 9.524 | 4.954 | 1.581 | 4.790 |
| 投入資產回報率 ROIC (%) | 2.349 | 11.615 | 6.025 | 1.971 | 5.771 | 邊際利潤分析 |
| 銷售毛利率 (%) | 82.480 | 82.112 | 68.514 | 51.189 | 43.908 |
| 營業利潤率 (%) | 13.627 | 15.813 | 9.434 | 3.524 | 6.505 |
| 息稅前利潤/營業總收入 (%) | 13.424 | 17.820 | 9.083 | 3.313 | 6.435 |
| 淨利潤/營業總收入 (%) | 10.762 | 14.636 | 7.280 | 2.358 | 5.383 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.306 | 55.349 | 48.685 | 82.088 | 60.710 |
| 價值變動淨收益/利潤總額(%) | 0.816 | 3.076 | 5.820 | 9.800 | 2.612 |
| 營業外收支淨額/利潤總額(%) | 0.112 | 11.487 | -1.864 | 0.401 | 1.716 | 償債能力分析 |
| 流動比率 (X) | 2.777 | 3.222 | 3.013 | 2.862 | 2.195 |
| 速動比率 (X) | 2.556 | 2.918 | 2.778 | 2.518 | 2.021 |
| 資產負債率 (%) | 24.044 | 19.815 | 19.525 | 19.152 | 26.341 |
| 帶息債務/全部投入資本 (%) | 0.072 | 0.994 | 2.640 | 1.042 | 6.217 |
| 股東權益/帶息債務 (%) | 138,637.758 | 9,903.742 | 3,659.095 | 9,411.095 | 1,495.803 |
| 股東權益/負債合計 (%) | 315.911 | 404.672 | 408.531 | 419.293 | 277.879 |
| 利息保障倍數 (X) | -61.321 | -399.550 | -50.797 | -14.698 | -35.132 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 8.570 | 14.782 | 18.959 | 51.747 | 41.859 |
| 存貨周轉天數 (天) | 164.894 | 159.470 | 87.714 | 57.785 | 29.651 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/06/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
